Guardant Health, Inc. (GH) CEO Helmy Eltoukhy on Q4 2019 - Earnings Call TranscriptSeeking Alpha • 02/25/20
Guardant Health (GH) Outpaces Stock Market Gains: What You Should KnowZacks Investment Research • 02/19/20
Guardant Health (GH) Dips More Than Broader Markets: What You Should KnowZacks Investment Research • 02/13/20
Has Guardant Health (GH) Outpaced Other Medical Stocks This Year?Zacks Investment Research • 01/30/20
Guardant Health Appoints High-Tech-Veteran Kumud Kalia Chief Information OfficerGlobeNewsWire • 01/21/20
Guardant Health Announces Collaboration With Amgen to Develop a Global Liquid Biopsy Companion Diagnostic for AMG 510 KRAS G12C InhibitorGlobeNewsWire • 01/13/20
Guardant Health and NRG Oncology Initiate Randomized Trial to Investigate Circulating Tumor DNA Guided Adjuvant Therapy in Stage II Colon CancerGlobeNewsWire • 01/13/20
Large-Scale Study Shows Guardant360 Effectively Guides Precision Oncology Treatment in Metastatic Breast Cancer PatientsGlobeNewsWire • 12/13/19